SUMMARY The duration of the acceleration phase of pulmonary systolic flow was measured by pulsed Doppler echocardiography in 39 normal subjects and 67 patients with heart disease to evaluate the reliability of this Doppler index as an estimate of pulmonary arterial pressure. The mean (SD) Doppler index in patients with abnormal mean pulmonary arterial pressure ( > 15 mm Hg) was significantly shorter than that in normal subjects (1 10 (30) ms vs 150 (10) ms). The Doppler index was significantly related to the mean pulmonary arterial pressure (r = -0 75) the pulmonary blood flow (r = 0 46), and the total pulmonary vascular resistance (r =-0-68). Forty four of 45 patients with an abnormal index (< 120 ms) showed abnormal mean pressure (> 15 mm Hg). Without exception patients with a low index ( < 90 ms) had distinct pulmonary hypertension ( > 25mm Hg). Twelve of 22 patients with a normal index (> 130 ms), however, also showed abnormal pressures. Nine of the 12 had an atrial septal defect and they had high pulmonary arterial pressure associated with high blood flow. Eighteen patients with valvar heart disease, whose mean pulmonary arterial pressure ranged from 16mm Hg to 24mm Hg, had a significantly shorter acceleration phase and a higher total vascular resistance than 11 patients with atrial septal defect in whom the pressure range was similar (120(20) ms vs 140(20) ms, 3 8 (1 1) hybrid resistance unit vs 1 6 (0-5)).
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Thus although the acceleration time of the pulmonary systolic flow is useful for the evaluation of pulmonary hypertension, it is a complex index that is affected not only by pulmonary arterial pressure but also by pulmonary blood flow and pathological changes in the pulmonary vascular bed.
Abnormal systolic flow patterns in the pulmonary artery and in the right ventricular outflow tract in patients with pulmonary hypertension 
Results
The systolic flow velocity curve in normal patients started at the beginning of systole and was sustained to the end of systole, peaking in mid-systole (fig 2) . In most patients with pulmonary hypertension, the peak of the flow velocity appeared prematurely, and there was a sharp decrease in flow velocity in midsystole (fig 4a) . The later part of the systolic curves showed two characteristic kinds of pattern, a reaccelerated flow that produced a second peak and a neutral or sometimes reversed flow (fig 4b) . One of . Ten of 11 patients with normal pressure ( < 15 mm Hg) showed a normal A T ( > 130ms). All 25 patients with mean pressure > 25mmHg had an abnormal value ( < 120 ms). Patients with an extremely short AT ( < 90ms) had distinct pulmonary hypertension ( > 25 mm Hg). Twelve of 22 patients with a normal A T, however, had abnormal pulmonary artery pressure. Nine of these 12 subjects had atrial septal defect (ASD). VHD, valvar heart disease. (r = -068, p< <00001 (fig 7) ). The correlation between acceleration time and pulmonary blood flow volume was not as strong as that between acceleration time and mean pulmonary arterial pressure (p < 0-001). Patients with atrial septal defect, whose pulmonary blood flow volume was generally high, tended to have longer acceleration times ( fig 6) . The correlation coefficient between acceleration time and total pulmonary vascular resistance was not significantly different from that between acceleration time and mean pulmonary arterial pressure.
The total pulmonary vascular resistance in patients with atrial septal defect with a normal acceleration time, however, tended to be low (fig 7) .
Relations between acceleration time and haemodynamic function appeared to be curvilinear ( fig 5  and fig 7) . When acceleration time was compared with logIo mean pulmonary arterial pressure (mPAP) and log,o total pulmonary vascular resistance (TPR), the correlation coefficients were Matsuda, Sekiguchi, Sugishita, Kuwako, Iida, Ito -0175 and -0179 respectively. Again there was no significant difference between these correlation coefficients. The regression equations for these relations were logio (mPAP) = 2-0-0-0057AT (F value = 83, SEE = 0-13), and log,o (TPR) = 1 8-0-010AT (F value = 108, SEE = 0-21) respectively, where AT is acceleration time and SEE is standard error of estimate.
The acceleration time in 11 patients with atrial septal defect in whom mean pulmonary arterial pressure ranged from 16 mm Hg to 24mmHg was significantly longer than that in 18 patients with valve disease in whom the range of mean pulmonary arterial pressures was similar (19(2) mm Hg vs 19(2) mmHg, NS; acceleration time (140(20)ms vs 120(10)ms, p < 0-005). The same patients with atrial septal defect had significantly lower total pulmonary vascular resistance than patients with valve disease (1-6(0 5) HRU vs 3 8(1 1) HRU, p < 0001). Patients with atrial septal defect in whom total pulmonary vascular resistance was increased and in whom pulmonary hypertension was severe had an abnormal acceleration time, however ( fig 5 and fig 7) . The correlation coefficient between acceleration time and mean pulmonary arterial pressure in patients with atrial septal defect was -0-87; in the remainder it was -0 78. The regression equation for acceleration time (AT) in patients with atrial septal defect was mPAP = 57-0-27AT (F value = 36, standard error of estimate = 48 mmHg) and that in the other patients was mPAP = 74-044AT (F value = 78, SEE = 8 0 mmHg).
In the three patients with severe right ventricular dysfunction the acceleration time was longer than normal (160-230 ms, table 2). We did not apply statistical tests to this small group. Right ventricular angiography showed a dilated right ventricle with poor systolic function and tricuspid regurgitation. There was a slight increase in mean pulmonary arterial pressure and total pulmonary vascular resistance, which we think is caused by a rise in pulmonary capillary pressure (table 2) .
Discussion
The acceleration time of pulmonary arterial systolic abnormal index had abnormal pulmonary arterial pressure. Without exception, patients with an extremely short acceleration time ( < 90 ms) had prominent pulmonary hypertension. In all patients with pulmonary hypertension the acceleration time was abnormal, and in most patients with normal pulmonary arterial pressure it was normal. Thus echocardiographic measurement of the acceleration phase of pulmonary arterial ejection flow at first appeared to be a promising non-invasive index of pulmonary hypertension.
In 12 of 22 patients with a normal index, however, pulmonary arterial pressure was abnormal (that is the mean pressure was > 15 mm Hg and < 25 mm Hg). Nine of these 12 patients had an atrial septal defect. In this study pulmonary blood flow was high in most patients with atrial septal defect. The acceleration time of ejection flow correlated not only with pulmonary arterial pressure, but also with pulmonary blood flow volume, that is the acceleration time increased with an increase in blood flow volume. Patients with an atrial septal defect and a normal Doppler index tended to have high pulmonary pressures associated with high blood flow volumes. Pulmonary vascular resistance was low in these patients. In contrast, the acceleration time was shorter than normal in patients with valvar heart disease, who had comparable pulmonary arterial pressure and higher peripheral resistance. The Doppler index was abnormal even in patients with atrial septal defect when pulmonary vascular resistance was increased. These results suggest that the duration of the acceleration phase of pulmonary systolic flow is more strongly influenced by pathological changes in the pulmonary vascular bed than by pulmonary arterial pressure itself.
The premature deceleration of pulmonary systolic flow in patients with pulmonary hypertension indicates that the pressure gradient between the right ventricular outflow tract and the pulmonary artery is reversed and counteracts systolic flow earlier than usual. In an earlier study we proposed two mechanisms to explain this early reversal of the pressure gradient in patients with pulmonary hypertension3: that decreased distensibility of the vessel wall8 may increase the amplitude of the pressure wave propagated from the right ventricular outflow tract into the pulmonary trunk; and that the reflection of the pressure wave at the peripheral vascular bed is increased by reduced vessel calibre or obstruction of the pulmonary arterioles and capillaries, so that the 163 reflected wave front reaches the pulmonary trunk prematurely through the stiffened vessels in such patients. These two mechanisms would result in an earlier reversal of the pressure gradient, that in turn would produce earlier deceleration of pulmonary systolic flow.
Our results are compatible with the finding reported by Milnor et al that pressure wave velocity was highest in the subjects with the highest pulmonary vascular resistance at any given mean pressure.9 They suggested that the increases in pulmonary arterial pulse wave velocity and impedance in their patients were not entirely due to passive distension of the artery by high transmural pressure, and that the pathological stiffening of the larger arteries in patients with high vascular resistance was greater than that produced by an uncomplicated increase in distending pressure. Patients with high pulmonary vascular resistance are likely to have histological alterations both in the peripheral vascular bed and in the large arteries; these will cause higher pressure peaks, a higher flow velocity, and a larger reflection of the pressure pulse wave. All of these effects will result in an earlier deceleration of pulmonary systolic flow than in patients with low pulmonary vascular resistance.
The acceleration phase of pulmonary systolic flow was prolonged in three patients with severe right ventricular dysfunction. Mean pulmonary arterial pressure and total peripheral vascular resistance were slightly increased. The increase may have resulted from raised pulmonary venous pressure rather than histological changes in the pulmonary arteries. Impaired ventricular contraction alone might not cause an early deceleration of pulmonary systolic flow if the pulmonary vascular bed is normal. In these three patients right ventricular angiography showed pronounced tricuspid regurgitation. Kitabatake et al reported that the good correlation between the Doppler acceleration index and mean pulmonary arterial pressure held irrespective of underlying tricuspid regurgitation; however, the acceleration time tended to be short in patients with mild or moderate tricuspid regurgitation.5 This may indicate that the Doppler acceleration index is not strongly affected by tricuspid regurgitation.
Although the acceleration time of pulmonary systolic flow is a useful index for the evaluation of pulmonary hypertension, it is affected by pulmonary arterial pressure, pulmonary blood flow, and histological changes in the pulmonary vascular bed. The acceleration time is a specific but not a sensitive index of pulmonary arterial pressure. An abnormal index indicates raised blood pressure with high peripheral resistance, but a normal index does not exclude raised blood pressure associated with high blood flow. Separate evaluation of each disease group should, however, improve the accuracy of this index. The correlation coefficient between acceleration time and mean pulmonary arterial pressure in patients with atrial septal defect was -0 87 (SEE 4 8mmHg)) and that in the remainder of patients was -0-78 (SEE 8-0 mm Hg). This Doppler index is also suitable for the assessment of the pulmonary vasular bed.
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